Merck Annual Report 2013 - Sitemap (optimized for printing)

Transformation on track
- Letter from
  Karl-Ludwig Kley
- Executive Board
- Financial Calendar
- Merck Group
- Merck Serono
- Consumer Health
- Performance Materials
- Merck Millipore
Group Management Report
- Fundamental Information about the Group
  - Divisions
    - Merck Serono
    - Consumer Health
    - Performance Materials
    - Merck Millipore
  - Objectives and strategies
    - Principles and Group strategy
    - Strategic initiatives
    - Business strategies of the divisions
    - Strategic financial and dividend policy
  - Internal management system
    - Group and Division KPIs
    - Capital Market-Related Parameters
    - Other Performance Measures
  - Corporate Responsibility
    - Society
    - Employees
    - Products
    - Environment
  - Research and Development
    - Merck Serono
      - Merck Serono pipeline
      - Overview compounds
    - Consumer Health
    - Performance Materials
    - Merck Millipore
    - Collaborations
  - Merck Shares
    - Share data
    - Shareholder
- Report on Economic Position
  - Macroeconomic environment
  - Review of forecast
  - Course of business and economic position
    - Business development
    - Expenses
    - Result
    - Assets and liabilities
    - Business free cash flow
    - Rating
    - Overall assessment
  - Merck Serono
    - Business development
    - Regions
    - Major products
    - Expenses
    - Result
    - Business Free Cash Flow
  - Consumer Health
    - Business development
    - Regions
    - Expenses
    - Result
    - Business Free Cash Flow
  - Performance Materials
    - Business development
    - Regions
    - Expenses
    - Result
    - Business Free Cash Flow
  - Merck Millipore
    - Business development
    - Regions
    - Business units
    - Expenses
    - Result
    - Business Free Cash Flow
  - Corporate and Other
- Report on Risks and Opportunities
  - Business-related risks and opportunities
  - Risks and opportunities of product quality and availability
  - Financial risks and opportunities
  - Legal risks
  - Risks and opportunities in human resources
  - Risks and opportunities of information technology
  - Environmental and safety risks
- Report on Expected Developments
  - Merck Group
  - Merck Serono
  - Consumer Health
  - Performance Materials
  - Merck Millipore
  - Summary
- Capital and shares
- Subsequent Events
Corporate Governance
- Statement on Corporate Governance
  - Merck KGaA
  - Statement of Compliance
  - Compensation report
    - Executive Board
    - Supervisory Board
    - Ownership of shares
- Corporate Governance Practices
  - Principles
  - Values and compliance
- Procedures of the corporate bodies
  - Executive Board
  - Supervisory Board
  - Board of Partners of E. Merck KG
- Report of the
  Supervisory Board
- Objectives of the Supervisory Board
Financial Statements
- Income Statement
- Comprehensive Income
- Balance Sheet
- Cash Flow Statement
- Changes in Net Equity
Notes
- General
  - Company information
  - Reporting principles
- Scope of consolidation
  - Changes in the scope of consolidation
  - Acquisitions and divestments
- Accounting policies
  - Accounting and measurement principles
  - Management judgments and sources of estimation uncertainty
  - Consolidation methods
  - Currency translation
  - Recognition of sales and other revenue
  - Research and development
  - Financial instruments: Principles
  - Financial instruments: Categories and classes of financial instruments
  - Financial instruments: Derivative and hedging relationships
  - Other non-financial assets and liabilities
  - Inventories
  - Intangible assets
  - Property, plant and equipment
  - Leasing
  - Deferred taxes
  - Provisions
  - Provisions for pensions and other post-employment benefits
- Notes to the consolidated income statement
  - Sales
  - Royalty, license and commission income
  - Cost of sales
  - Marketing and selling expenses
  - Royalty, license and commission expenses
  - Administration expenses
  - Other operating expenses and income
  - Research and development
  - Amortization of intangible assets
  - Financial result
  - Income tax
  - Non-controlling interest
  - Earnings per share
- Notes to the balance sheet
  - Cash and cash equivalents
  - Current financial assets
  - Trade accounts receivable
  - Inventories
  - Other assets
  - Tax receivables
  - Intangible assets
  - Property, plant and equipment
  - Non-current financial assets
  - Financial liabilities
  - Trade accounts payable
  - Other liabilities
  - Tax liabilities
  - Provisions
  - Provisions for pensions and other post-employment benefits
  - Equity
- Segment reporting
  - Information by division/country and region
  - Information on segment reporting
- Notes to the consolidated cash flow statement
  - Net cash flows from operating activities
  - Net cash flows from investing activities
  - Business free cash flow
- Other disclosures
  - Derivative financial instruments
  - Management of financial risks
  - Other disclosures on financial instruments
  - Capital management
  - Contingent liabilities
  - Other financial obligations
  - Personnel expenses/Headcount
  - Material costs
  - Auditors' fees
  - Corporate governance
  - Companies opting for exemption under section 264 (3) HGB or section 264b HGB
  - Related-party disclosures
  - Executive Board and Supervisory Board compensation
  - Information on preparation and approval
  - Subsequent events
  - List of shareholdings
- Auditor's Report
Business Development 2009-2013